Mail

UK markets close in 4 hours 12 minutes

FTSE 100
8,171.93
+29.78(+0.37%)
FTSE 250
20,305.21
+145.49(+0.72%)
AIM
777.93
+3.00(+0.39%)
GBP/EUR
1.1836
+0.0002(+0.01%)
GBP/USD
1.2690
-0.0015(-0.12%)
Bitcoin GBP
51,484.26
-449.15(-0.86%)

What Labour and the Tories are offering pensioners in their manifestos

Read what the party manifestos have to say about pension policy

Cannabis Bioscience International Holdings, Inc. (CBIH)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD

Add to watchlist

0.0017

+0.0011

(+183.33%)

At close: 03:59PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	17.96M
Enterprise value	18.45M
Trailing P/E	0.10
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.01
Price/book (mrq)	0.01
Enterprise value/revenue	0.14
Enterprise value/EBITDA	0.58

Trading information

Stock price history

Beta (5Y monthly)	-0.24
52-week change ³	331.25%
S&P500 52-week change ³	24.71%
52-week high ³	0.0018
52-week low ³	0.0003
50-day moving average ³	0.0007
200-day moving average ³	0.0007

Share statistics

Avg vol (3-month) ³	8.52M
Avg vol (10-day) ³	27.81M
Shares outstanding ⁵	10.38B
Implied shares outstanding ⁶	11.33B
Float ⁸	5.67B
% held by insiders ¹	39.90%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 May 2023
Most-recent quarter (mrq)	29 Feb 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	-439.35%

Management effectiveness

Return on assets (ttm)	-539.77%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	219.39k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	-29.00%
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-791.41k
Diluted EPS (ttm)	0.0200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	794
Total cash per share (mrq)	0
Total debt (mrq)	488.85k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.02
Book value per share (mrq)	-0.00

Cash flow statement

Operating cash flow (ttm)	-492.79k
Levered free cash flow (ttm)	32.37k